Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Erythroblastic, Acute

Explore clinical trials studying Leukemia, Erythroblastic, Acute. Study availability and eligibility vary by location and protocol.

130 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Erythroblastic, Acute trial results

Completed

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

NCT00462761

Conditions
AML, Acute Myeloid Leukemia, Aortic aneurysm, familial thoracic 4, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia
View Trial Details
Completed

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

NCT00509093

Conditions
Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission

NCT00045435

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations
  • OHSU Cancer Institute Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML

NCT00895934

Conditions
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +26 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Harrison HealthPartners Hematology and Oncology-Bremerton Bremerton, Washington, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • University of Washington Medical Center Seattle, Washington, United States
View Trial Details
Completed

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

NCT01031368

Conditions
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +31 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions